Untitled

LIVER, BILIARY TRACT AND PANCREAS PROBLEMS

INTRODUCTION TO PATIENT CASES

• Patient 1: Matthew Ramsey

  • 52-year-old male
  • Presents to ED (Emergency Department) with severe right upper quadrant (RUQ) pain.
  • Pain onset: 4 hours after consuming fried chicken dinner.
  • Associated symptoms: nausea, vomiting, sweating.
  • Past medical history (PMH): Type 2 diabetes, obesity (BMI 34).

• Patient 2: Reggie Perks

  • 48-year-old male
  • Presents to ED with severe epigastric pain lasting 6 hours.
  • Pain description: "boring" and radiates to back.
  • Associated symptoms: nausea, vomiting (3 episodes).
  • PMH: Alcohol use disorder (daily drinking), smoking (1 pack per day for 30 years).

• Patient 3: Kim Fringe

  • 32-year-old female
  • Presentation: Severe nausea, vomiting, jaundice, confusion.
  • History: Ingested "extra-strength" acetaminophen (unknown dosage) for migraine 3 days prior.
  • Admission: From ED to ICU (Intensive Care Unit).

• Patient 4: Jill Haney

  • 58-year-old female
  • History: Alcoholic cirrhosis (20+ years of heavy drinking).
  • Chief complaint: Vomiting large amounts of dark blood.
  • Admission: From ED to ICU.

• Patient 5: Quinn Trew

  • 58-year-old male
  • History: Alcoholic cirrhosis (20+ years of heavy drinking).
  • Admission: Found confused at home.
  • Chief complaint: Altered mental status, "not making sense."
  • Recent history: Missed lactulose doses for 3 days, constipated.

ASSESSMENTS

Patient 1: Matthew Ramsey

• Pain assessment: Severe RUQ pain rated 9/10, steady and non-colicky.
• Radiation of pain: Pain radiates to right shoulder/scapula.
• Physical signs: Tachycardia, diaphoresis, restlessness.
• Physical exam finding: Positive Murphy's sign.
• Skin examination: Sclera appear slightly yellow, indicating possible jaundice.

Patient 2: Reggie Perks

• Pain assessment: Severe epigastric tenderness with guarding.
• Preferred position: Patient prefers sitting up and leaning forward.
• Abdominal signs: Decreased bowel sounds and abdominal distention.
• Overall appearance: Diaphoretic and appears acutely ill.

Patient 3: Kim Fringe

• Mental status: Confused, disoriented to time.
• Skin examination: Jaundiced sclera and yellow skin tone.
• GI symptoms: Severe nausea, vomiting, RUQ abdominal pain.
• Bleeding signs: Petechiae on arms and gingival bleeding present.
• Neurological assessment: Exhibits asterixis (flapping tremor).

Patient 4: Jill Haney

• Physical appearance: Pale, diaphoretic, anxious.
• Abdominal assessment: Distended abdomen with fluid wave (ascites).
• Skin findings: Jaundiced, presents spider angiomas on chest.
• Vomitus characteristics: Dark red blood resembling "coffee grounds."
• Mental status: Alert but confused, indicative of early encephalopathy.

Patient 5: Quinn Trew

• Mental status: Confused, disoriented to time and place.
• Neurological signs: Asterixis, hyperreflexia.
• Speech pattern: Slurred speech with slow responses.
• Behavioral assessment: Agitated with inappropriate responses.
• Motor skills: Poor coordination, unsteady gait noted.

VITAL SIGNS

Patient 1: Matthew Ramsey

• Blood Pressure (BP): 142/88 mmHg.
• Heart Rate (HR): 110 bpm (tachycardia).
• Respiratory Rate (RR): 22 breaths/min.
• Temperature: 101.2°F (38.4°C).
• Oxygen Saturation (SpO₂): 96% on room air.

Patient 2: Reggie Perks

• Temperature: 100.4°F (38°C).
• Heart Rate: 118 bpm.
• Blood Pressure: 98/62 mmHg.
• Respiratory Rate: 26 breaths/min.
• Oxygen Saturation: 94% on room air.

Patient 3: Kim Fringe

• Blood Pressure: 98/62 mmHg (hypotensive).
• Heart Rate: 118 bpm (tachycardic).
• Respiratory Rate: 24/min (tachypneic).
• Temperature: 38.2°C (100.8°F).
• Oxygen Saturation: 94% on room air.

Patient 4: Jill Haney

• Blood Pressure: 88/54 mmHg (hypotensive).
• Heart Rate: 128 bpm (tachycardic).
• Respiratory Rate: 26 breaths/min (tachypneic).
• Temperature: 98.2°F (afebrile).
• Oxygen Saturation: 92% on room air.

Patient 5: Quinn Trew

• Blood Pressure: 128/76 mmHg (stable).
• Heart Rate: 88 bpm, regular rhythm.
• Respiratory Rate: 18 breaths/min.
• Temperature: 98.4°F (36.9°C).
• Oxygen Saturation: 96% on room air.
• Weight: 182 lbs (increased from baseline due to ascites).

LABS

Patient 1: Matthew Ramsey

• WBC: 15,200/mm³ (elevated).
• Alkaline Phosphatase: 285 U/L (elevated).
• ALT: 178 U/L, AST: 165 U/L (both elevated).
• Total Bilirubin: 3.2 mg/dL (elevated).
• Direct Bilirubin: 2.1 mg/dL (elevated).
• Urinalysis: Dark amber urine, bilirubin present.

Patient 2: Reggie Perks

• Serum Amylase: 1,240 U/L (markedly elevated).
• Serum Lipase: 2,180 U/L (markedly elevated).
• WBC: 18,200/mm³ (elevated).
• Glucose: 248 mg/dL (elevated).
• Calcium: 7.2 mg/dL (decreased).
• Triglycerides: 156 mg/dL (normal).

Patient 3: Kim Fringe

• Liver Enzymes: AST 3,200 U/L, ALT 2,800 U/L (both markedly elevated).
• Bilirubin: Total 12.8 mg/dL (severe hyperbilirubinemia).
• PT/INR: PT 42 sec, INR 4.2 (prolonged coagulation).
• Ammonia: 180 mcg/dL (elevated).
• Glucose: 58 mg/dL (hypoglycemia).
• Creatinine: 2.1 mg/dL (renal impairment).

Patient 4: Jill Haney

• Hemoglobin: 7.2 g/dL (critical low).
• Hematocrit: 22% (critical low).
• Platelets: 68,000/μL (thrombocytopenia).
• INR: 2.8 (coagulopathy).
• BUN: 42 mg/dL (elevated).
• Creatinine: 1.8 mg/dL (elevated).
• Ammonia: 95 mcg/dL (elevated).

Patient 5: Quinn Trew

• Ammonia: 180 mcg/dL (normal range: 15-45 mcg/dL).
• AST/ALT: Mildly elevated indicating end-stage pattern.
• Bilirubin: 4.2 mg/dL (elevated-jaundice).
• Albumin: 2.4 g/dL (low indicating malnutrition).
• PT/INR: Prolonged (INR 2.6 - coagulopathy).
• Electrolytes: Hypokalemia, hyponatremia noted.

DIAGNOSTICS

Patient 1: Matthew Ramsey

• Ultrasound Findings:

  • Multiple gallstones visualized in gallbladder.
  • Thickened gallbladder wall (5 mm).
  • Presence of pericholecystic fluid.
  • Positive sonographic Murphy's sign.
  • Common bile duct diameter: 8 mm (dilated).

• ERCP (Endoscopic Retrograde Cholangiopancreatography):

  • ERCP performed to visualize the biliary tree:
  • Stone identified in the common bile duct.
  • Bile sample obtained for culture.
  • Stone successfully extracted.
  • Sphincterotomy performed to alleviate blockage.

Patient 2: Reggie Perks

• Abdominal Ultrasound Results:

  • Found pancreatic edema and peripancreatic fluid.

• Contrast-Enhanced CT Scan Results:

  • Diffuse pancreatic enlargement with areas of necrosis observed.

• Chest X-ray Findings:

  • Left pleural effusion and signs of basilar atelectasis.

Patient 3: Kim Fringe

• Acetaminophen Level: 85 mcg/mL (toxic).
• Viral Hepatitis Panel: Negative results.
• CT Abdomen: Liver edema with no masses identified.
• Toxicology Screen: Negative for other substances.

Patient 4: Jill Haney

• Upper GI Endoscopy Results:

  • Large esophageal varices with active bleeding identified.

• Liver Elastography Findings:

  • Severe fibrosis/cirrhosis confirmed.

• Type & Crossmatch:

  • 6 units of PRBCs ordered for transfusion.

• Abdominal Ultrasound Findings:

  • Splenomegaly, ascites, portal vein dilation.

• Chest X-ray Results:

  • Clear lung fields.

Patient 5: Quinn Trew

• Ammonia Levels: 180 mcg/dL (elevated).
• Liver Function Tests:
  • AST and ALT mildly elevated (end-stage liver failure pattern).
  • Bilirubin elevated at 4.2 mg/dL (jaundice).
  • Albumin low at 2.4 g/dL (malnutrition).

COMPLICATIONS

Patient 1: Matthew Ramsey

• Most common complication: Pancreatitis.
• Possible complications include:
  • Bleeding from the sphincterotomy site.
  • Perforation of duodenum or bile duct.
  • Infection/cholangitis.
  • Aspiration during sedation (risk during ERCP).

Patient 2: Reggie Perks

• Severe complications include:
  • Acute necrotizing pancreatitis → potential for infection or sepsis.
  • Formation of pseudocysts leading to rupture and hemorrhage.
  • Acute respiratory distress syndrome (ARDS) → respiratory failure risk.
  • Acute kidney injury due to hypovolemia.
  • Hypocalcemia, leading to symptoms such as tetany and cardiac dysrhythmias.

Patient 3: Kim Fringe

• Possible complications include:
  • Hepatic encephalopathy (graded 1-4).
  • Cerebral edema leading to increased intracranial pressure (ICP).
  • Renal failure (hepatorenal syndrome).
  • Coagulopathy resulting in bleeding risk.
  • Hypoglycemia, which can cause seizures or coma.
  • Sepsis leading to multiorgan failure.

Patient 4: Jill Haney

• Possible complications include:
  • Active hemorrhage which poses a life-threatening risk.
  • Hypovolemic shock causing organ hypoperfusion.
  • Hepatorenal syndrome leading to acute kidney injury.
  • Hepatic encephalopathy resulting from ammonia toxicity.
  • Risk of infection due to bacterial translocation to ascites.
  • Recurrence of bleeding; 70% chance of rebleeding without treatment.

Patient 5: Quinn Trew

• Complications may include:
  • Cerebral edema with consequent increased ICP.
  • Aspiration risk due to decreased level of consciousness (LOC).
  • Risk of falls and injuries due to confusion and poor coordination.
  • Hepatorenal syndrome due to decreased renal perfusion.
  • Risk of progression to coma without treatment for encephalopathy (grades 3-4).
  • Increased infection risk leading to sepsis which can worsen encephalopathy.

TREATMENTS

Patient 1: Matthew Ramsey

• Priority Interventions Post-ERCP:

  • Maintain NPO (nothing by mouth) until gag reflex returns post-sedation.
  • Monitor vitals every 15 minutes for the first 4 hours, then every hour.
  • Assess for any severe abdominal pain.
  • Monitor amylase and lipase levels for signs of pancreatitis.
  • Advance diet slowly from clear liquids to a low-fat diet.

• Surgical Intervention:

  • Gold standard treatment for symptomatic cholelithiasis.
  • Laparoscopic approach preferred over open surgery.
  • Typically involves 4 small incisions.
  • Patients can be discharged on the same day or observed for no more than 23 hours post-surgery.

Patient 2: Reggie Perks

• NPO Status: Maintain to rest the pancreas.
• Aggressive IV Fluid Resuscitation: Administer Lactated Ringer's solution to restore fluid balance.
• Pain Management: Administer IV opioids such as morphine or hydromorphone.
• Oxygen Therapy: Maintain SpO₂ > 95%.
• NG Tube: Place if severe vomiting or abdominal distention is present.
• Antibiotic Therapy: Initiate if necrosis or infection is suspected based on clinical findings.

Patient 3: Kim Fringe

• N-acetylcysteine (NAC): Administer as an antidote for acetaminophen poisoning.
• Aggressive IV Fluids: To maintain hemodynamic stability and restore perfusion.
• Dextrose Infusions: To correct hypoglycemia.
• Vitamin K / FFP: To correct coagulopathy and prevent bleeding complications.
• Lactulose / Rifaximin: To reduce ammonia levels and prevent encephalopathy.
• Liver Transplant Evaluation: Consider for definitive treatment in cases of fulminant hepatic failure.

Patient 4: Jill Haney

• Fluid Resuscitation: Establish 2 large-bore IVs (14-16 gauge) for aggressive crystalloid resuscitation.
• Blood Products: Administer PRBCs, FFP, and platelets as indicated by lab values.
• Vasopressors: Use Octreotide to reduce portal pressure and related bleeding risks.
• Endoscopic Therapy: Options include band ligation or sclerotherapy for variceal hemorrhage.
• Balloon Tamponade: Leverage if the patient is unresponsive to other measures.
• Antibiotics: Administer as prophylaxis against infection due to elevated risk with variceal bleeding.

Patient 5: Quinn Trew

• Lactulose: Administer to trap ammonia in the gut and promote its elimination through defecation.
• Rifaximin: Use to reduce the population of ammonia-producing bacteria.
• Electrolyte Correction: Replace potassium and normalize sodium levels.
• Protein Management: Carefully maintain nutrition while controlling ammonia production by limiting excess protein intake.
• Treatment of Precipitants: Address underlying causes like constipation and avoid sedatives that worsen hepatic encephalopathy.
• Liver Transplant: Evaluated as a definitive treatment option for advanced liver disease.

NURSING INTERVENTIONS

Patient 1: Matthew Ramsey

• Respiratory Status: Conduct deep breathing exercises and utilize incentive spirometry.
• Pain Management: Apply multimodal analgesia plans tailored to efficacy and side effects.
• Early Mobility: Ambulation within 12 hours to prevent postoperative complications.
• Surgical Site Monitoring: Watch for signs of bleeding or bile leakage.
• Complication Assessment: Check for shoulder pain indicative of CO₂ retention during laparoscopy and monitor nausea/vomiting (N/V).

Patient 2: Reggie Perks

• Hemodynamic Monitoring: Regularly check BP, HR, central venous pressure (CVP), and urine output.
• Strict Intake & Output: Assess fluid balance rigorously to manage renal function.
• Respiratory Assessment: Monitor for prevention of atelectasis and ARDS (acute respiratory distress syndrome).
• Pain Assessment: Frequent and thorough reassessments of pain levels.
• Infection Monitoring: Watch for signs like fever or elevated WBC count.

Patient 3: Kim Fringe

• Neurological Checks: Monitor mental status and conduct checks every 2 hours to assess changes indicating encephalopathy progression.
• Head Of Bed (HOB): Elevate to 30° to help reduce intracranial pressure.
• Avoid Straining: Prevent Valsalva maneuver to avoid spikes in blood pressure and ICP.
• Safety Protections: Implement fall precautions, ensure padded rails on beds, and overall patient safety measures.
• Glucose Monitoring: Conduct frequent assessments (every 2-4 hours) to prevent hypoglycemia.
• Strict I&O: Monitor fluid output to protect renal function.
• Nephrotoxic Drug Avoidance: Exclude NSAIDs and aminoglycosides from administration.

Patient 4: Jill Haney

• Airway Protection: Maintain elevated HOB, suction as needed, and implement aspiration precautions.
• Hemodynamic Monitoring: Check vital signs every 15 minutes and maintain hourly I&O and ECG monitoring.
• IV Access & Fluids: Ensure two large-bore IVs remain available for blood products and fluids.
• NG Tube Management: Assess aspirate for blood and properly position the tube.
• Respiratory Assessment: Auscultate breath sounds and monitor oxygen saturation continuously.
• Safety Measures: Employ fall precautions suitable for patients with altered mental states.

Patient 5: Quinn Trew

• Safety First: Maintain fall precautions with bed alarms and frequent rounding.
• Neurologic Monitoring: Assess level of consciousness (LOC) every 2 hours and document behavior.
• Medication Administration: Deliver lactulose and rifaximin according to orders.
• Bowel Management: Monitor bowel frequency closely to prevent constipation.
• Fluid and Electrolyte Balance: Thoroughly assess I&O and replace potassium as needed.
• Airway Protection: Position the patient safely and ensure suction is readily available.

PATIENT EDUCATION

Patient 1: Matthew Ramsey

• Dietary Instructions: Initiate a low-fat diet (first 4-6 weeks post-surgery), gradually reintroduce foods while avoiding fried items, fatty meats, and cream sauces.
• Meal Frequency: Recommend small, frequent meals as they are better tolerated by patients.
• Follow-up Care: Important for monitoring post-surgical recovery and any recurring symptoms.

Patient 2: Reggie Perks

• Alcohol Abstinence: Essential to prevent further pancreatic damage.
• Smoking Cessation: Critical to improve overall health and recovery.
• Dietary Recommendations: Advise on maintaining a low-fat diet for 4-6 weeks and report severe pain, fever, steatorrhea (fatty stools), or hyperglycemia promptly.
• Follow-up Monitoring: Regularly assess for developing diabetes or pancreatic insufficiency.

Patient 3: Kim Fringe

• Acetaminophen Safety: Advise maximum daily dose limit (3,000 mg) and reading all pharmaceutical labels for hidden acetaminophen.
• Alcohol Avoidance: Critical for preventing liver damage progression.
• Transplant Possibility: Prepare the family for discussion about potential liver transplantation.
• Follow-up: Ongoing monitoring for liver function is essential.

Patient 4: Jill Haney

• Medication Adherence: Emphasize importance of beta-blockers for reducing portal pressure.
• Alcohol Abstinence: Critical to stop liver damage progression.
• Dietary Modifications: Strict low-sodium diet and protein intake management necessary.
• Warning Signs: Teach patients to recognize warning signs for acute situations, specifically when to seek emergency care.
• Follow-up Care: Regularly scheduled endoscopy for varices surveillance as part of ongoing care.

Patient 5: Quinn Trew

• Medication Adherence: Importance of taking lactulose regularly to prevent episodes of encephalopathy.
• Alcohol Abstinence: Reinforce the critical importance of avoiding alcohol.
• Constipation Prevention: Encourage fluid intake, fiber diet, and reporting missed bowel movements swiftly.
• Warning Symptoms: Teach warning signs such as confusion or changes in personality.
• Protein Management: Ensure adequate nutrition while avoiding excessive protein intake to lower ammonia loads.
• Avoidance of Hepatotoxic Drugs: Guidance against taking high doses of acetaminophen, among others.

KEY POINTS

Patient 1: Matthew Ramsey

• Gallstone Etiology: Gallstones form due to supersaturated bile; classic presentation involves RUQ pain following the consumption of fatty meals.
• ERCP Role: ERCP effectively treats duct stones; practicing cholecystectomy is essential for preventing recurrence.

Patient 2: Reggie Perks

• Pathophysiology: Autodigestion results from premature enzyme activation within the pancreas; primary etiologies for pancreatitis include gallstones in women and alcohol use in men.
• Diagnostic Criteria: Elevated lipase more specific than amylase for pancreatitis diagnosis.
• Life-Threatening Risks: Patients risk developing infected necrosis, ARDS, and potential shock following pancreatitis events. Prevention strategies include alcohol abstinence and adherence to low-fat dietary practices.

Patient 3: Kim Fringe

• Acetaminophen Overdose Pathophysiology: Leading cause of acute liver failure in the U.S.; characterized by the triad of jaundice, coagulopathy, and encephalopathy.
• Progression Insights: Rapid hourly deterioration is possible; timely administration of NAC is critical within 16 hours for optimal outcomes.
• Transplant Consideration: Early evaluation may be indicated at grades 1-2 encephalopathy levels given prognosis implications.

Patient 4: Jill Haney

• Major Complications of Liver Disease: Portal hypertension can lead to the development of esophageal varices and life-threatening hemorrhaging; priority initial assessment includes airway protection when hematemesis occurs.
• Understanding BUN Levels: Elevated BUN alongside normal creatinine levels suggests GI bleeding.
• Treatment Efficiency: Octreotide decreases portal pressure, and endoscopic treatment for immediate bleeding is crucial to patient survival—with a high recurrence risk without intervening treatment.

Patient 5: Quinn Trew

• Neurological Assessment Importance: Ammonia accumulation leads to severe brain toxicity with resultant cognitive issues; serial assessments every 2 hours help dictate ongoing therapy effectiveness.
• Management Overarching Strategy: Lactulose is crucial for ammonia trapping and elimination, while rifaximin works to reduce ammonia-producing gut flora.